This means that the episode rankings aren't working properly. Please revisit us at a later time to get the best episodes of this podcast!
© 2019 OwlTail All rights reserved. OwlTail only owns the podcast episode rankings. Copyright of underlying podcast content is owned by the publisher, not OwlTail. Audio is streamed directly from Dan Valancius servers. Downloads goes directly to publisher.
Turning Kids Into Grown-Ups. Parenting is fraught with uncertainty, changing with each generation. This hour, TED speakers share ideas about raising kids and how — despite our best efforts — we're probably still doing it wrong. Guests include former Stanford dean Julie Lythcott-Haims, former firefighter Caroline Paul, author Peggy Orenstein, psychologist Dr. Aala El-Khani, and poet Sarah Kay.
Parenting Doesn't Matter (Or Not As Much As You Think). The multibillion-pound parenting industry tells us we can all shape our children to be joyful, resilient and successful. But what if it’s all bunk? Intelligence Squared are bringing together a panel of top geneticists and parenting experts to explore just how important parenting is.Arguing in favour of the motion are Robert Plomin, Psychologist and Professor of Behavioural Genetics at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London; and Stuart Ritchie, Lecturer in the Social Genetic and Developmental Psychiatry Centre at King’s College London.Arguing against the motion were Susan Pawlby, a developmental Clinical Psychologist with over 30 years of experience working with mothers and babies both in clinical and research contexts; and Ann Pleshette Murphy, a therapist, parenting counsellor and advocate for young children and their families.The debate was chaired by Xand van Tulleken, a medical doctor and broadcaster who has presented numerous shows for the BBC and Channel 4, often alongside his identical twin brother Chris. For information regarding your data privacy, visit acast.com/privacy
Episode 26: Living Long Enough to Live Forever. In Episode 6, Peter and Dan described how mindset plays a key role in living a long, healthy life, this time they share stories about how they each arrived at their ambitious longevity goals. In this episode: Peter talks about Ray Kurzweil’s belief that children born today will have the ability to have an indefinite lifespan. Dan describes his thoughts on attitude and why the future is something you must work toward. Peter puts into perspective the amazing times we are living in, citing how the human lifespan has doubled over the last century. Dan mentions his visit to Human Longevity Inc., for the full story, listen to Episode 21 here.
#17 Nick Littlehales - Improve your sleep. Nick is regarded as the leading elite sports sleep coach in world sport. A leading industry expert with over 30 years experience in the world of sleep, sleeping habits, and product design and over 15 years dedicated to elite athletes and professional sport. For more information about Nick visit sportsleepcoach.co.uk For more information about Mind Set Game connect with us on Facebook @mindsetgamepodcast. For more information about James Roberts (the host of the podcast), visit fitamputee.co.uk
Rank #1: HELP! Episode 5: Chest Pain - Testing, Testing, 1, 2.... James Knight MD, Beth Liston MD, PhDEpisode 5 of the HELP podcastWhat happens when you analyze the testing and outcomes of nearly 1 million ED chest pain visits? We'll talk about this great recent article from Dr. Sandhu et al. at Stanford. We are friends and colleagues from THE Ohio State University.Article via https://www.ncbi.nlm.nih.gov/labs/articles/28654959/JAMA Intern Med. 2017;177(8):1175-1182.Opinions are our own and not those of our employer.
Rank #2: HELP! Episode 4: SHM17 Research and Innovation Posters. James Knight MD, Vijay Duggirala MD, Eric Nolan MDEpisode 4 of the HELP podcastDifferent format as we discuss posters from the Research and Innovation Poster Session and SHM17 in beautiful Las Vegas, NV. We are friends and colleagues from THE Ohio State University.Opinions are our own and not those of our employer.
Rank #1: Square Peg, Round Hole: Securing The Mission of Medicine (Walter Bortz, M.D.). Dr. Bortz is a Clinical Associate Professor of Medicine at Stanford University School of Medicine. He discusses the importance of physical exercise in the promotion of robust aging with the goal of fulfilling the mission of medicine.
Rank #2: Getting Smart about Urinary Tract Infections (Christopher J. Graber, MD, MPH). This lecture was given at the "Get Smart About Antibiotics" lecture series given as part of the UCLA Antimicrobial Stewardship Program.
Rank #1: Towards a Cure for Castleman Disease: One Doctor's Personal Journey . Host: John J. Russell, MD Guest: David Fajgenbaum, MD Castleman disease, a rare idiopathic multicentric disorder, is diagnosed in approximately 5000 people in the United States each year. When one 3rd year medical student suddenly found himself facing this diagnosis personally, at a time when knowledge about the disease was minimal, he helped create a broad-based initiative to address this knowledge gap. Host Dr. John Russell talks with Dr. David Fajgenbaum, a Research Assistant Professor of Medicine in Translational Medicine/Human Genetics and Associate Director of Patient Impact for the Penn Orphan Disease Center at the University of Pennsylvania. He is also co-founder of the Castleman Disease Collaborative Network, a global initiative dedicated to accelerating research and treatment for Castleman disease and improving survival for all patients.
Rank #2: Strategies for Success: Exercising Our Mental Muscle . Host: Brian P. McDonough, MD, FAAFP Guest: Kisma Orbovich Improvement is something we’re all constantly chasing, whether it’s in the form of a promotion, a bigger house, or maybe even an ideal weight. So why do we often fail miserably at these attempts to make our lives better? To get to the bottom of this dilemma, Dr. Brian McDonough is joined by Kisma Orbovich, the CEO of Illumination Academy, to reveal the secret to true success and how gratitude may just be the lifehack we’ve been searching for.
Rank #1: Thomas F. Patterson, MD, FACP, FIDSA - Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider. Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider
Rank #2: Robert Z. Orlowski, MD, PhD - Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics. Go online to PeerView.com/TXD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in the management of MM discusses the implications of recent efficacy and safety data that support the ongoing integration and use of several innovative treatments, such as antibody-based therapies, next-generation IMiDs and proteasome inhibitors, and novel therapies directed against intracellular targets. The expert also provides a review of the overall shape of MM therapy in newly diagnosed and relapsed disease, and discusses strategies to manage treatment-related adverse effects. Upon completion of this activity, participants will be able to: Summarize updated evidence on the use of novel agent classes and next-generation therapeutics in multiple myeloma (MM), including proteasome inhibitors, immunomodulators (IMiDs), novel antibodies, and targeted agents, Select appropriate therapy in patients with newly diagnosed MM, including those requiring eradication of MRD or treatment for high-risk disease, Recommend therapy with novel components for patients with early relapse or treatment-refractory MM, Manage treatment-related adverse events in patients with MM who are receiving novel therapeutics as part of their care.
Rank #1: Internal Medicine Pearls Part 1.
Rank #2: Internal Medicine Pearls #3. A look at some new data: COPD and Oxygen use - low serum creatinine levels - BMI considerations - the RDW - the age of blood.
Rank #1: Hypertension 3: antihypertensives. Listen to Tina the pharmacist discuss the 5 first-line antihypertensives: Thiazides ACE Inhibitors Angiotensin Receptor Blockers Beta Blockers Calcium Channel Blockers She lists the mechanism of action, dosing, side effects, drug interactions, and cautionary notes of each drug classes and their representative drug. This episode is wrapped up with Billy’s summary of the learning points from the 3-episode series on Hypertension: essential hypertension is a diagnosis of exclusion. we need to consider treatable causes of hypertension especially for people who do not have the usual risk factors. diagnosing a patient with hypertension is a careful process. for those without comorbidities or cardiovascular treatment, it can take a many as 5 visits averaging a BP of 140/90 to make a diagnosis. use home BP measurement if you suspect white coat hypertension. the treatment threshold for uncomplicated patients is 160/100, and threshold for those with end organ damage or increased CV risk is 140/90. a trial of lifestyle management to control BP is appropriate for most uncomplicated patients. it should always be a part of the management plan even for those who are on medication. Treatment target is 140/90, unless the patient has diabetes, for this the threshold is 130/80. For an elderly patient above 80 yo, systolic treatment target is 150 the first line agents are thiazides, ACEI, ARB, BB, and CCB. specific agents may be indicated for specific comorbidities antihypertensive are among the most commonly used medications, but one must not forget that they carry many potentially serious side effects and can interact with other medications. when in doubt, consult your favorite pharmacist The post Hypertension 3: antihypertensives appeared first on Family Pharm Podcast.
Rank #2: CHF 1: CCS 2012 Guideline. We turned our attention to chronic congestive heart failure (CHF) and reviewed “The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update“. National Institute of Health provided a great summary on CHF for patients and the public: http://www.nhlbi.nih.gov/health/health-topics/topics/hf/ For a basic anatomy review of the circulatory system: Anatomy of the heart. Source: Wikimedia. For another diagram showing the heart in relation to the body, click here. And an over-simplification of the pathophysiology of left vs right heart failure is that when the left ventricle fails, not enough oxygenated blood gets pumps to the body to meet its demand. Instead, blood gets backed up into the lungs and cause fluid buildup in the lungs. This pressure can further back up into the right heart, such that the right ventricle and right atrium cannot accommodate a normal amount of venous return, and fluid can accumulate in the body to cause edema. Wikipedia strikes a good balance of depth and readability on this topic: http://en.wikipedia.org/wiki/Heart_failure The CCS guideline suggests the following investigations for CHF: CXR, echocardiography, BNP, labs (CBC, electrolytes, creatinine, urinalysis, glucose, thyroid function), and further testing (nuclear imaging, catheterization, stress test, MRI, CT, endomyocardial biopsy) if appropriate. The CCS guideline on treatment of chronic CHF: ACE inhibitors for: all symptomatic HF patients and EF < 40%. all patients with an EF < 35% Angiotensin receptor blocker: if patient intolerant to ACEI add to ACEI if intolerant or contraindicated for BB add to ACEI and BB if patient has NYHA class II-IV HF and EF ≤ 40% deemed at increased risk of HF events Beta blocker: all HF patients with an EF ≤ 40% initiated at a low dose and titrated to the target dose or maximal tolerated dose Mineralocorticoid receptor antagonist: EF <30% and one of the following: past MI and HF diabetes severe chronic HF (NYHA IIIB-IV) despite optimized treatment age >55 with HF symptoms on treatment and recent hospitalization for CV disease in the past 6 months (or if QRS duration > 130ms and EF <35%) with elevated BNP or NT-proBNP levels Diuretics: loop diuretic, such as furosemide, for most patients with HF and congestive symptoms. When acute congestion is cleared, the lowest dose should be used that is compatible with stable signs and symptoms persistent volume overload despite optimal medical therapy and increases in loop diuretics, cautious addition of a second diuretic (a thiazide or low dose metolazone) may be considered as long as it is possible to closely monitor morning weight, renal function, and serum potassium Digoxin: patients in sinus rhythm who continue to have moderate to severe symptoms, despite optimized HF therapy patients with chronic atrial fibrillation (AF) and poor control of ventricular rate Isosorbide dinitrate and hydralazine: black Canadians with HF-REF non-black HF patients unable to tolerate an ACE inhbitor or ARB The post CHF 1: CCS 2012 Guideline appeared first on Family Pharm Podcast.
Rank #1: Hypertensive Crisis with Dr. Lorrel Brown. Dr. Lorrel Brown discusses the Hypertensive Crisis by first defining hypertension. She then defines hypertensive crisis as having severely elevated blood pressure with end-organ damage. After, she discusses the pathophysiology of end organ damage along with the different treatment approaches for hypertensive crisis. Finally, she finishes her presentation with a few case reports. Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page.Disclaimers©2016 LouisvilleLectures.org
Rank #2: Acute CVA with Dr. Jignesh Shah. Dr. Shah presents Acute CVA by first explaining how to evaluate a stroke patient, define a stroke and TIA as well as stroke epidemiology. He then discusses the concept of penumbra along with vascular anatomy and pathogenesis. After talking through the risk factors and classifying Ischemic stroke, Dr. Shah finishes with the signs and symptoms of a stroke. Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page.Disclaimers©2016 LouisvilleLectures.org
Rank #1: Timing of Dialysis Initiation. Interview with Peter P. Reese, MD, MSCE and Vishnu S. Potluri, MD, MPH, authors of Honoring Patient Preferences in Initiation of Dialysis: Problems, Proposals, and a Path Forward, and Susan P. Y. Wong, MD, author of Timing of Initiation of Maintenance Dialysis: A Qualitative Analysis of the Electronic Medical Records of a National Cohort of Patients From the Department of Veterans Affairs
Rank #2: Changes in Functional Status in the Year After Aortic Valve Replacement. Interview with Dae Hyun Kim, author of Evaluation of Changes in Functional Status in the Year After Aortic Valve Replacement, and Emily Finlayson, MD, MS, author of Invasive Procedures to Improve Function in Frail Older Adults: Do Outcomes Justify the Intervention?
Rank #1: Serious Bacterial Infections in HIV-Infected Adults. Presented by Dr. Majid Sadigh during the ongoing Makerere Univ./Yale Univ. Collaboration. Selected topics include infections with Rhodococcus, Mycobacteria, Bartonella, and Salmonella.
Rank #2: Pneumocystis Jiroveci Pneumonia. Presented by Dr. Majid Sadigh in Kampala, Uganda as a part of the collaboration between Makerere University and Yale University
Rank #1: CCP Podcast 090: Mechanical Ventilation with Thomas. I thought it was time we explored the subject of mechanical ventilation again and so I reached out on Twitter and am now joined by Thomas Piraino (@respresource) who is a Clinical Specialist in mechanical ventilation at the Centre of Excellence in Mechanical Ventilation, St. Michael’s Hospital. We start with the basic modes and what is […] The post CCP Podcast 090: Mechanical Ventilation with Thomas appeared first on Critical Care Practitioner.
Rank #2: CCP Podcast 077: NCEPOD 2017 Acute Non-Invasive Ventilation: Inspiring Change.. I think this might be one of the most important podcasts I have ever done along with the next in the series. This is the first of two podcasts covering the latest NCEPOD paper on Non-Invasive Ventilation. This can also be found on the NCEPOD web page, but they also kindly agreed to allow me […] The post CCP Podcast 077: NCEPOD 2017 Acute Non-Invasive Ventilation: Inspiring Change. appeared first on Critical Care Practitioner.
Rank #1: COPD. Inhaled corticosteroids for COPD; "Lovenox Hurts," by Samantha Jaglowski, MD, of Ohio State University in Columbus; plus a summary of all the articles in the issue.
Rank #2: Diabetes. Intensive glycemic control for type 2 diabetes; interview with Victor Montori, MD, of the Mayo Clinic, Rochester; plus a summary of all the articles in the issue.
Rank #1: Abdominal Pain. A Case Based Approach to Acute Abdominal Pain in the ER
Rank #2: Anxiety and Panic Attacks. Brief discussion of the etiology and management of anxiety related disorders
Rank #1: Episode 471: Platelet-rich plasma injection not beneficial for nonoperative treatment. Dr. Ebell and Dr. Wilkes discuss the POEM titled "Platelet-rich plasma injection not beneficial for nonoperative treatment"
Rank #2: Episode 465: Monthly buprenorphine depot injections maintain abstinence in patients with opioid use disorders. Dr. Ebell and Dr. Wilkes discuss the POEM titled "Monthly buprenorphine depot injections maintain abstinence in patients with opioid use disorders"
Rank #1: 5 Pearls Ep2: Iron Deficiency Anemia. Solidify your knowledge on iron deficiency anemia! Quiz yourself on the 5 Pearls we will be covering: Should patients be screened for iron deficiency? If so, who and how often? (1:40) What are the indications for diagnostic endoscopy in iron deficient patients? (3:23) How should you advice patients to take oral iron? (5:53) What is optimal dosing for oral iron? In which patients would you consider IV iron? What are the risks? (11:41) Throwback Question: What is a medication-overuse HA? (14:44)For full shownotes: https://www.coreimpodcast.com/2017/11/15/5-pearls-on-iron-deficiency-anemia/
Rank #2: #22 Proton-Pump Inhibitors: 5 Pearls segment. Solidify your knowledge on Proton-Pump Inhibitors (PPIs) and more! Quiz yourself on the 5 pearls we will be covering: What are associated adverse effects for patients are on long-term PPIs? (2:02) What are strategies to get your patient off PPIs? (10:57) How do histamine-2 (H2) receptor antagonists blockers work and how can it explain why H2 blockers might not be as effective as PPIs? (13:30) How should you educate patients to take PPIs to get the maximize benefit? (16:48) How do you manage ongoing symptoms in patients on PPIs? (21:41) For full transcript of the podcast and references: https://www.coreimpodcast.com/2018/08/29/5-pearls-on-ppis/
Rank #1: Gregory Piazza, MD, MS - Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden. Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
Rank #2: J. Sloan Manning, MD - Overcoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America. Overcoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America